F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229–263 (2024)

H. Rumgay, J. Ferlay, C. de Martel, D. Georges, A.S. Ibrahim, R. Zheng et al., Global, regional and national burden of primary liver cancer by subtype. Eur. J. Cancer 161, 108–118 (2022)

N.D. Ferrante, A. Pillai, A.G. Singal, Update on the diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterol. Hepatol. 16(10), 506–516 (2020)

Google Scholar 

Z.T. Al-Salama, Y.Y. Syed, L.J. Scott, Lenvatinib, Rev. Hepatocellular Carcinoma Drugs. 79(6), 665–674 (2019)

CAS  Google Scholar 

F.M. Fan, J.S. Fleishman, J. Chen, Z.S. Chen, H.H. Dong, New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma. Drug Discovery Today. 29(8), 104069 (2024)

Article  CAS  PubMed  Google Scholar 

W. Bo, Y. Chen, Lenvatinib resistance mechanism and potential ways to conquer. Front. Pharmacol. 14, 1153991 (2023)

Y. Wang, H. Chen, Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications. Oncogene. 42(24), 1970–1979 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Läubli, L. Borsig, Altered cell adhesion and glycosylation promote cancer immune suppression and metastasis. Front. Immunol. 10, 2120 (2019)

Google Scholar 

Z. Xu, T. Isaji, T. Fukuda, Y. Wang, J. Gu, O-GlcNAcylation regulates integrin-mediated cell adhesion and migration via formation of focal adhesion complexes. J. Biol. Chem. 294(9), 3117–3124 (2019)

E.P. Bennett, U. Mandel, H. Clausen, T.A. Gerken, T.A. Fritz, L.A. Tabak, Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 22(6), 736–756 (2012)

Article  CAS  PubMed  Google Scholar 

M.J. Huang, R.H. Hu, C.H. Chou, C.L. Hsu, Y.W. Liu, J. Huang et al., Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling. Oncotarget. 6(8), 5650–5665 (2015)

Article  PubMed  PubMed Central  Google Scholar 

Y.-M. Wu, C.-H. Liu, R.-H. Hu, M.-J. Huang, J.-J. Lee, C.-H. Chen et al., Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor. Cancer Res. 71(23), 7270–7279 (2011)

Y. Liu, W. Liu, L. Xu, H. Liu, W. Zhang, Y. Zhu et al., GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma. J. Urol. 192(5), 1534–1541 (2014)

Y. Liu, H. Liu, L. Yang, Q. Wu, W. Liu, Q. Fu et al., Loss of N-Acetylgalactosaminyltransferase-4 orchestrates oncoge Nic MicroRNA-9 in hepatocellular carcinoma. J. Biol. Chem. 292(8), 3186–3200 (2017)

R. Kimura, T. Yoshimaru, Y. Matsushita, T. Matsuo, M. Ono, J.-H. Park et al., The GALNT6–LGALS3BP axis promotes breast cancer cell growth. Int. J. Oncol. 56(2), 581–595 (2020)

B. Deng, Y.E. Tarhan, K. Ueda, L. Ren, T. Katagiri, J.-H. Park et al., Critical role of estrogen receptor alpha O-Glycosylation by N-Acetylga lactosaminyltransferase 6 (GALNT6) in its nuclear localization in breast cancer cells. Neoplasia. 20(10), 1038–1044 (2018)

J. Song, W. Liu, J. Wang, J. Hao, Y. Wang, X. You et al., GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78. Cell Death Dis. 11(5), 352 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Lachenmayer, S. Toffanin, L. Cabellos, C. Alsinet, Y. Hoshida, A. Villanueva et al., Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. J. Hepatol. 56(6), 1343–1350 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di P. Fazio, P. Waldegger, S. Jabari, S. Lingelbach, R. Montalbano, M. Ocker et al., Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer. Oncotarget. 7(20), 28998–29010 (2016)

Article  PubMed  PubMed Central  Google Scholar 

Z. Wang, J. Shen, C. Chen, T. Wen, C. Li, FOXA2 plays a critical role in hepatocellular carcinoma progression and lenvatinib-associated drug resistance. Biosci. Trends. 17(2), 136–147 (2023)

Article  CAS  PubMed  Google Scholar 

F. Hu, D. Song, Y. Yan, C. Huang, C. Shen, J. Lan et al., IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation. Nat. Commun. 12(1), 3651 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

W. Zhang, Y. Tang, P. Yang, Y. Chen, Z. Xu, C. Qi et al., TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy. Autophagy. 20(10), 2146–2163 (2024)

Article  CAS  PubMed  Google Scholar 

S. Wang, H. Cheng, M. Li, D. Gao, H. Wu, S. Zhang et al., BNIP3-mediated mitophagy boosts the competitive growth of Lenvatinib-resistant cells via energy metabolism reprogramming in HCC. Cell Death Dis. 15(7), 484 (2024)

Article  CAS  PubMed  PubMed Central  Google Scholar 

W. Hou, B. Bridgeman, G. Malnassy, X. Ding, S.J. Cotler, A. Dhanarajan et al., Integrin subunit beta 8 contributes to lenvatinib resistance in HCC. Hepatol. Commun. 6(7), 1786–1802 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S.E. Tollefsen, R. Kornfeld, The B4 lectin from Vicia villosa seeds interacts with N-acetylgalactosamine residues alpha-linked to serine or threonine residues in cell surface glycoproteins. J. Biol. Chem. 258(8), 5172–5176 (1983)

Article  CAS  PubMed  Google Scholar 

D. Raghu, R.J. Mobley, N.A.M. Shendy, C.H. Perry, A.N. Abell, GALNT3 maintains the epithelial state in trophoblast stem cells. Cell. Rep. 26(13), 3684–97e7 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D.J. Gill, K.M. Tham, J. Chia, S.C. Wang, C. Steentoft, H. Clausen et al., Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proc. Natl. Acad. Sci. U.S.A. 110(34), E3152–E3161 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Zeng, Z. Ye, R. Shen, G. Yu, J. Wu, Y. Xiong et al., IOBR: Multi-omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and signatures. Front. Immunol. 12, 687975 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Zeng, Y. Fang, P. Luo, W. Qiu, S. Wang, R. Shen et al., IOBR2: multidimensional decoding tumor microenvironment for immuno-oncology research. (2024). https://doi.org/10.1101/2024.01.13.575484.

G. Korotkevich, V. Sukhov, N. Budin, B. Shpak, M.N. Artyomov, Sergushichev A. Fast gene set enrichment analysis. 060012 (2016)

K. Yoshihara, M. Shahmoradgoli, E. Martínez, R. Vegesna, H. Kim, W. Torres-Garcia et al., Inferring Tumour Purity Stromal Immune cell. Admix. Expression data. 4(1), 2612 (2013)

Google Scholar 

E. Becht, N.A. Giraldo, L. Lacroix, B. Buttard, N. Elarouci, F. Petitprez et al., Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17(1), 218 (2016)

Article  PubMed  PubMed Central  Google Scholar 

P. Jiang, S. Gu, D. Pan, J. Fu, A. Sahu, X. Hu et al., Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24(10), 1550–1558 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Fu, K. Li, W. Zhang, C. Wan, J. Zhang, P. Jiang et al., Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 12(1), 21 (2020)

Article  PubMed  PubMed Central  Google Scholar 

T. Stuart, A. Butler, P. Hoffman, C. Hafemeister, E. Papalexi, W.M. Mauck et al., Comprehensive integration of single-cell data. Cell. 177(7), 1888–1902. e21 (2019)

CAS  Google Scholar 

Y. Zhang, T. Liu, X. Hu, M. Wang, J. Wang, B. Zou et al., CellCall: integrating paired ligand–receptor and transcription factor activities for cell–cell communication. Nucleic Acids Res. 49(15), 8520–8534 (2021)

Y. Zhang, L. Sun, C. Lei, W. Li, J. Han, J. Zhang et al., A sweet warning: mucin-type O-glycans in cancer. Cells. 11(22), 3666 (2022)

H.O. Duarte, D. Freitas, C. Gomes, J. Gomes, A. Magalhães, C.A. Reis, Mucin-type O-Glycosylation in gastric carcinogenesis. Biomolecules. 6(3), 33 (2016)

I. Sanz-Martinez, S. Pereira, P. Merino, F. Corzana, R. Hurtado-Guerrero, Molecular recognition of GalNAc in mucin-type O-glycosylation. Acc. Chem. Res. 56(5), 548–560 (2023)

E.P. Bennett, U. Mandel, H. Clausen, T.A. Gerken, T.A. Fritz, L.A. Tabak, Control of mucin-type O-glycosylation: a classification of the polypep tide GalNAc-transferase gene family. Glycobiology. 22(6), 736–756 (2016)

J. Pan, M. Zhang, L. Dong, S. Ji, J. Zhang, S. Zhang et al., Genome-scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma. Autophagy. 19(4), 1184–1198 (2023)

Article  CAS  PubMed  Google Scholar 

A. Magalhães, H.O. Duarte, C.A. Reis, The role of O-glycosylation in human disease. Mol. Aspects Med. 79, 100964 (2021)

Article  PubMed  Google Scholar 

A.D. Ladd, S. Duarte, I. Sahin, A. Zarrinpar, Mechanisms of drug resistance in HCC. Hepatology (Baltimore Md). 79(4), 926–940 (2024)

Y. Qin, S. Han, Y. Yu, D. Qi, M. Ran, M. Yang et al., Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy. 2024

X. Mao, J. Xu, W. Wang, C. Liang, J. Hua, J. Liu et al., Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol. Cancer. 20(1), 131 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Q. Chen, J. Luo, J. Liu, H. Yu, M. Zhou, L. Yu et al., Integrating single-cell and spatial transcriptomics to elucidate the crosstalk between cancer-associated fibroblasts and cancer cells in hepatocellular carcinoma with spleen-deficiency syndrome. J. Traditional Complement. Med. 14(3), 321–334 (2024)

Article